Equities

Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Ltd

Actions
Health CareHealth Care Equipment & Services
  • Price (AUD)29.33
  • Today's Change0.49 / 1.70%
  • Shares traded319.58k
  • 1 Year change96.19%
  • Beta0.5284
Data delayed at least 20 minutes, as of Apr 01 2020 03:04 BST.
More ▼

Profile data is unavailable for this security.

About the company

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.

  • Revenue in NZD (TTM)1.13bn
  • Net income in NZD233.00m
  • Incorporated1954
  • Employees4.55k
  • Location
    Fisher & Paykel Healthcare Corporation Ltd15 Maurice Paykel Place, East TamakiAUCKLAND 1061New ZealandNZL
  • Phone+64 95740100
  • Fax+64 95740158
  • Websitehttps://www.fphcare.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.